2005
DOI: 10.1016/j.bcp.2005.02.022
|View full text |Cite
|
Sign up to set email alerts
|

Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

15
269
3
6

Year Published

2007
2007
2021
2021

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 294 publications
(293 citation statements)
references
References 40 publications
15
269
3
6
Order By: Relevance
“…Chen et al (94) examined the flavonoids viz. apigenin, quercetin, kaempferol and myricetin for their proteasomeinhibitory and apoptosis-inducing abilities in human leukemia cells.…”
Section: Apigenin and Leukemiamentioning
confidence: 99%
“…Chen et al (94) examined the flavonoids viz. apigenin, quercetin, kaempferol and myricetin for their proteasomeinhibitory and apoptosis-inducing abilities in human leukemia cells.…”
Section: Apigenin and Leukemiamentioning
confidence: 99%
“…After 2 h incubation at 37 °C, inhibition of the proteasomal chymotrypsin-like activity was measured (Chen et al, 2005b).…”
Section: Synthesis Of Bis(1-pyrrolidinecarbodithioato-ksks′)copper(imentioning
confidence: 99%
“…The prepared whole cell extracts (30 μg per sample) were then incubated with 40 μM of Ac-DEVD-AMC in 100 μL assay buffer at 37 °C for at least 2 h. The release of the AMC groups was measured as previously described (Chen et al, 2005b).…”
Section: Synthesis Of Bis(1-pyrrolidinecarbodithioato-ksks′)copper(imentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, flavonoids exert specific cytotoxic activity towards cancer cells which has generated large interest in devel-0939Ð5075/2008/0500Ð0347 $ 06.00 " 2008 Verlag der Zeitschrift für Naturforschung, Tübingen · http://www.znaturforsch.com · D oping flavonoid-based cytostatics for anticancer therapy (Galati and O'Brien, 2004). Different mechanisms are linked to flavonoid-mediated cytotoxicity, including proteasome inhibition (Chen et al, 2005), inhibition of fatty acid synthesis (Brusselmans et al, 2005), topoisomerase inhibition (Constantinou et al, 1995), inhibition of phosphatidyl-inositol 3-kinase (Agullo et al, 1997), induction of cell cycle arrest (Lepley et al, 1996), induction of p53 (Plaumann et al, 1996) or enhanced expression of c-fos and c-myc proto-oncogenes (Chen et al, 1998).…”
Section: Introductionmentioning
confidence: 99%